echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Shenzhen will be An Sansa, Jie Kewei and other 6 drugs into the serious illness medical insurance

    Shenzhen will be An Sansa, Jie Kewei and other 6 drugs into the serious illness medical insurance

    • Last Update: 2019-03-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    the original title: Shenzhen will Be An Sansa, Jie Kewei and other 6 kinds of drugs into the serious illness medical insurance
    According to the Guangzhou Daily reported, Shenzhen decided to add six varieties of antacid Alitini capsules (commodity name "An Sansa") into the "Shenzhen Heavy Disease Supplementary Medical Insurance Drug Catalog", effective From July 1, 2019Shenzhen's supplementary medical insurance for serious diseases (supplementary medical insurance) was established in 2015 and is a further extension and supplementary improvement based on Shenzhen's original basic medical insurance and local supplementary medical insurance, aiming to reduce the burden precisely for those who suffer from serious illnessofficial data show that as of November 2018, shenzhen basic health insurance coverage of about 14.5 million people, serious illness supplementary insurance coverage of 7.05 million people, has paid a total of 439,000 people, a cumulative compensation of 531 million yuanthe original 11 varieties of the "catalog", has now 6 completely (4) or part (2) into the basic medical insurance drug catalog, in order to smoothly do a good job of supplementary insurance related work convergence, to protect the legitimate rights and interests of the insured, the urgent need to add to the Directoryrecently, the Shenzhen Municipal People's Social Bureau issued a notice on the addition of "Shenzhen Heavy Disease Supplementmedical MedicineS) notice, the hydrochloric acid Aletini capsule (Ansansha), Paboli pearl mono-injection (Korida), Olapari tablets (Lipjo), phosphate reedini tablets (Jebuwei), pyresili capsules (Aibo new ®), injection acetate (Somadulin) 6 supplementary varietiesthis supplementary variety is included in the government procurement documents for the supplementary insurance service from July 1, 2019 to June 30, 2022, and the serious illness supplement insurance insured will also enjoy the relevant reimbursement treatment of the new 6 varieties from July 1, 2019the insured from this year, in the insurance contribution period (May-June each year) to pay for the supplementary insurance for serious illness, you can normally enjoy the relevant reimbursement treatment of this new 6 varieties in accordance with the policyCopyright Notice: This article is transferred from Guangzhou Daily, if you do not wish to be reproduced by the media or individuals can contact us, we will immediately delete
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.